Cargando…

What can we learn from cancer of unknown primary in canine oncology?

Cancer of unknown primary (CUP) represents a heterogeneous group of metastatic tumors that lack an identifiable primary site despite an extensive diagnostic work-up. It is a well-recognized entity that is characterized by early dissemination, aggressive clinical course, unpredictable metastatic patt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khazzaka, Aline, Rassy, Elie, Pavlidis, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303049/ https://www.ncbi.nlm.nih.gov/pubmed/32577312 http://dx.doi.org/10.1016/j.jare.2020.06.002

Ejemplares similares

Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?
por: Rassy, Elie, et al.
Publicado: (2020)

Can Precision Oncology Benefit Patients With Cancers of Unknown Primary?
por: Rassy, Elie, et al.
Publicado: (2023)

Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered
por: Rassy, Elie, et al.
Publicado: (2020)

Changing the landscape of European School of Oncology–European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic
por: Pavlidis, Nicholas, et al.
Publicado: (2022)

Data on clinical significance of second trimester inflammatory biomarkers in the amniotic fluid in predicting preterm delivery
por: Kesrouani, Assaad, et al.
Publicado: (2016)

Hepatitis of unknown etiology in children: What we know and what we can do?
por: Zhu, Mingyu, et al.
Publicado: (2022)

From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary
por: Mathew, Beatrice Gadiel, et al.
Publicado: (2023)

Learning by Debate: Innovative Tool in the Hematology-Oncology Fellowship Program
por: Samaha, Ramy, et al.
Publicado: (2021)

Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of Oncology
por: Pavlidis, Nicholas, et al.
Publicado: (2021)

What Cardio-Oncology Lessons Can We Learn From Population-Based Data?
por: Klimis, Harry, et al.
Publicado: (2022)

Correction to: Eight-Year Experience of the Certifcate of Competence and Advanced Studies Program Organized by the European School of Oncology
por: Pavlidis, Nicholas, et al.
Publicado: (2021)

Geriatric Radiation Oncology: What We Know and What Can We Do Better?
por: Roeder, Falk, et al.
Publicado: (2023)

A mini review on cancer of unknown primary site: A clinical puzzle for the oncologists
por: Pavlidis, Nicholas, et al.
Publicado: (2015)

Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities
por: Boussios, Stergios, et al.
Publicado: (2021)

Oncology nurse: Psychological nursing for cancer patients, what can we do?
por: Lu, Yuhan
Publicado: (2022)

Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model
por: Hemminki, Kari, et al.
Publicado: (2016)

What can we learn from the hair of the dog? Complex effects of endogenous and exogenous stressors on canine hair cortisol
por: Packer, Rowena M. A., et al.
Publicado: (2019)

COVID-19 and Gynecologic Oncology: What Have We Learned?
por: Leibold, Aurora, et al.
Publicado: (2021)

What Can We Learn from Medical Whistleblowers?
por: Lenzer, Jeanne
Publicado: (2005)

What can we learn from Plausible Values?
por: Marsman, Maarten, et al.
Publicado: (2016)

What can we learn from honey bees?
por: Schwartzman, Julia A
Publicado: (2021)

Aging: What We Can Learn From Elephants
por: Chusyd, Daniella E., et al.
Publicado: (2021)

Jets: what we can still learn....
por: Humpert, Benedikt, et al.
Publicado: (1984)

Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
por: Boussios, Stergios, et al.
Publicado: (2019)

Perspective On Excellence in Forensic Mental Health Services: What We Can Learn From Oncology and Other Medical Services
por: Kennedy, Harry G., et al.
Publicado: (2019)

Canine infectious respiratory disease: Tackling the unknown unknowns
por: Priestnall, S.L., et al.
Publicado: (2012)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

Oncologic emergency in patients with skeletal metastasis of unknown primary
por: Torigoe, Tomoaki, et al.
Publicado: (2021)

COVID-19 Imaging: What We Know Now and What Remains Unknown
por: Kanne, Jeffrey P., et al.
Publicado: (2021)

Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
por: Moschetta, Michele, et al.
Publicado: (2020)

The FIRE AND ICE Trial: What We Know, What We Can Still Learn, and What We Need to Address in the Future
por: Kuck, Karl‐Heinz, et al.
Publicado: (2018)

What can we learn from geographical comparisons of childhood cancer survival?
por: Pritchard-Jones, K, et al.
Publicado: (2007)

Cancer Microenvironment: What Can We Learn from the Stem Cell Niche
por: Lacina, Lukas, et al.
Publicado: (2015)

Prostate cancer screening: what can we learn from randomised trials?
por: Auvinen, Anssi
Publicado: (2018)

Skin Cancer Microenvironment: What We Can Learn from Skin Aging?
por: D’Arino, Andrea, et al.
Publicado: (2023)

Responses to Drought Stress in Poplar: What Do We Know and What Can We Learn?
por: Rosso, Laura, et al.
Publicado: (2023)

Commentary: Perspective on excellence in forensic mental health services: What we can learn from oncology and other medical services
por: Manzone, Maria Laura, et al.
Publicado: (2022)

What can we learn from drug marketing efficiency?
por: Kao, David P
Publicado: (2008)

What we can learn from the next generation of experiments
por: Ross, Graham G
Publicado: (1981)

Neuroblastoma Mass Screening—What Can We Learn From It?
por: Katanoda, Kota
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sjetus3jgadfiq5gvhel8p5hf5